does semaglutide cause naion GLP-1 Medications and NAION: What Patients Should Know About Sudden Vision Loss GLP-1 medications and eye problem

Description

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

Millions of patients now use these medicines for blood sugar control, weight reduction, and cardiovascular risk improvement

While this transformation can be life changing, rapid or significant weight reduction often leaves behind loose skin

These findings demonstrate that both basal and agonist-induced GLP-1R phosphorylation are critical for receptor signalling in -cells, revealing a previously unappreciated role for basal phosphorylation in shaping receptor behaviour and establishing a positive link between GLP-1R phosphorylation and -cell signalling competence